Reported about 2 months ago
Eli Lilly has introduced a new, more affordable version of its obesity drug Zepbound to help those without insurance access the medication. The new pricing includes a 2.5 mg single-dose vial at $399 per month and a four-week supply of the 5 mg dose for $549, which is significantly lower than the previous cost of around $1,000 per month. However, these doses will be sold in vials requiring a syringe and needle instead of the injector pens used for more expensive doses.
Source: YAHOO